Navigation Links
CancerCare Launches New Program to Help Multiple Myeloma Patients Cover Transportation Costs
Date:7/20/2009

NEW YORK, July 20 /PRNewswire/ -- CancerCare announced today the launch of the "Door to Door" program for patients with multiple myeloma. CancerCare's program will provide individual grants of up to $600 annually to multiple myeloma patients for covering transportation costs such as gasoline and taxi, bus or train fare to and from their medical care.

The program is funded in part by a generous grant from Millennium: The Takeda Oncology Company. CancerCare is a national non-profit organization based in New York City that provides free support services to people affected by cancer.

Multiple myeloma is a cancer of the bone marrow that is diagnosed in approximately 20,000 people annually in the U.S. Advances in the treatment of this cancer have dramatically increased patients' life expectancy (an estimated 60,000 people in the U.S. are now living with multiple myeloma) and consequently lengthened the duration of treatment.

"Because of the nature of their therapies and the disease itself, many multiple myeloma patients may be required to visit their doctors several times a week over many months. Particularly for patients on a fixed income, these travel expenses add up and create a financial burden that may prevent them from keeping up with their health care," noted Diane Blum, executive director of CancerCare. "The Door to Door program will provide much-needed relief to this patient population, and we are grateful for Millennium's support."

Founded in 1944, CancerCare has a long track record of providing financial assistance to people facing cancer; it is a cornerstone of its direct support services to help people cope with the emotional and practical issues of a cancer diagnosis. During fiscal year 2009, CancerCare provided over $4.2 million in grants to more than 24,000 people with cancer to
'/>"/>

SOURCE CancerCare
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
2. UPMC Health Plan Launches New Personal Health Record
3. HealthInsuranceFinders.com Launches Video Contest for Young Directors
4. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
5. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
6. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
7. Mannatech Launches Phase One of New Sales and Training Tools
8. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
9. Actavis Launches Carvedilol Tablets in the U.S.
10. MedQuist Re-launches New, Improved Web Site
11. Elsevier launches new journal: Stem Cell Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... , ... July 04, 2015 , ... The Harvest Hope Food Bank will ... Four local AlignLife offices in the area of Greenville SC are making it ... be made by patients only. They are asking for donations from the public as well. ...
(Date:7/3/2015)... ... July 03, 2015 , ... On June ... a new SEO training system called "Page One Engine" . The program, ... has received glowing reviews from several well-known marketers. HonestyFirstReviews.com's Tiffany Hendricks has joined ...
(Date:7/3/2015)... ... ... Scientists at several top US cancer centers believe they now know why certain ... to read the complete story , just posted on the Surviving Mesothelioma website. ... New York University exposed mice with a mutation on the tumor suppressor gene called ...
(Date:7/3/2015)... ... July 03, 2015 , ... B. E. Smith, the ... to lead a national president recruitment for Regional Care, Inc. in ... B. E. Smith has recently placed more than 1,000 healthcare executives into organizations. ...
(Date:7/3/2015)... ... 2015 , ... The Erie County Bar Association Institute of ... Association welcomed speaker C. Daniel McGillicuddy Esq. of William Mattar Law Offices. ... these types of cases. , Each year, New York State residents are hospitalized ...
Breaking Medicine News(10 mins):Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2
... of successful hepatitis C virus (HCV) therapy in African Americans ... the antiviral activity induced by interferon. The study is ... of Infectious Diseases , now available online. , More than ... countries more than 10 percent of the population is infected. ...
... some groups, survival odds after angioplasty are not as ... major international study pinpoints which people with major heart ... than artery-opening angioplasty. , "Bypass surgery is preferable for ... Hlatky, professor of health research and policy and cardiovascular ...
... of Interest Tracking Helps Mainstream Management ProcessSTUART, Fla., ... Health Systems, a not-for-profit, community-based healthcare organization covering ... track potential conflicts of interests for its board ... healthcare system based in a moderately sized community, ...
... Barbara, California, offshore oil spill gave birth to new ... in environmental protection worldwide. Since then, environmental regulation has ... performance and has contributed to a deepening confrontation between ... of politics and society. , In his new ...
... Healthcare Conference and Expo will provide employers and health ... during a June 1-3, 2009 conference in Kansas City, ... employer rather than a conference promoter. Deffenbaugh,s ... event to help educate employers and plan sponsors on ...
... at Uppsala University, together with colleagues at the Karolinska ... the genes the determine the dosage of the blood-thinning ... journal PLoS Genetics . , "We have previously ... that we have gone in and scanned the entire ...
Cached Medicine News:Health News:2-day results predict ultimate response to therapy in chronic hepatitis C 2Health News:Diabetics and Elderly May Fare Better With Bypass 2Health News:Diabetics and Elderly May Fare Better With Bypass 3Health News:MediTract's Compliance Management Tools Improve Efficiencies at Martin Memorial Health Systems 2Health News:MediTract's Compliance Management Tools Improve Efficiencies at Martin Memorial Health Systems 3Health News:MediTract's Compliance Management Tools Improve Efficiencies at Martin Memorial Health Systems 4Health News:MediTract's Compliance Management Tools Improve Efficiencies at Martin Memorial Health Systems 5Health News:An even-handed analysis of environmental policy 2Health News:Deffenbaugh Industries to Host Self-Funding Healthcare Conference in Kansas City 2
(Date:7/2/2015)... 2, 2015 Roche,s Bloodhound technology is ... segment in hematology testing, according to Kalorama Information.  ... unveiling of its Bloodhound digital cell imaging technology ... 511 hematology analyzer – is notable as ... by current leader CellaVision, but also compete more ...
(Date:7/2/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/n7kzjb/vitamin_d_market ) has ... Analog, Application, End-User & by Region - Global Trends & ... This market is projected to reach about $2.5 Million by ... and rising opportunities in countries such as India ... , and Brazil . In 2013, ...
(Date:7/2/2015)... --  EVO Aesthetic Center and Wellness Spa prides ... in Lakeway, Texas and will ... Duality laser. The medical spa is focused on helping ... laser procedures. Their addition of the Astanza Duality will ... their tattoo regret. "The large number of ...
Breaking Medicine Technology:Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 3Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3EVO Offers Advanced Laser Tattoo Removal With Astanza Duality In Lakeway, TX 2
... Inc.,(Nasdaq: ENCO ), a full service multinational ... countries for many of the world,s,leading pharmaceutical and ... and Prologue have mutually agreed to postpone,negotiations regarding ... of the two companies have decided to form ...
... Helix BioPharma announced,today that it has received the ... to expand upon its clinical trial with Topical,Interferon ... presently,underway in Sweden., "We are pleased to ... said John Docherty, President of Helix BioPharma. "The,opening ...
Cached Medicine Technology:Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig 2Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig 3Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig 4Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 2Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 3Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 4
Used to introduce balloon, electrode, closed or non-tapered end catheters and other devices for intervention....
Used to introduce balloon, closed and non-tapered end catheters or other devices for intervention....
Sheath Introducers with guidewires....
Used to introduce balloon, electrode, closed or non-tapered end and,other catheters....
Medicine Products: